Overview
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
Status:
Completed
Completed
Trial end date:
2007-05-01
2007-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study represents the first administration of GSK376501 in humans and the goal is to evaluate its initial safety and tolerability. The way the human body processes GSK376501 will also be determined.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
GlaxoSmithKline
Criteria
Inclusion:- Healthy
- Non-smoking
- Overweight or obese subjects with a BMI between 27 and 35.
Exclusion:
- Women who are pregnant, lactating, or are of child-bearing potential